Peptide library › Cancer & imaging
Gallium Ga-68 dotatate
Also known as NETSPOT, 68Ga-DOTATATE
Radioactive tracer used in PET scans to find neuroendocrine tumours.
What people use it for
- Locating somatostatin receptor-positive neuroendocrine tumours on PET scans
What Gallium Ga-68 dotatate does in the body
A somatostatin-like peptide carrying gallium-68, which gives off signals a PET scanner can see, lighting up tumours with somatostatin receptors.
Strength of evidence
Strong: more accurate than older scan methods for these tumours.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Very few; a small radiation dose
- Nausea (rare)
Who should avoid it or take extra care
- Pregnancy or breastfeeding, unless a specialist advises it
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2016 for adults and children. Imaging centres only.
How it's taken
Route: Single injection into a vein before the scan
How long it lasts (half-life): Gallium-68 loses half its radioactivity every 68 minutes
Storage
Stored and prepared by the pharmacy or clinic, following the product label.
Latest research & news
- Neuroendocrine Neoplasms: Somatostatin Receptor and Fluorodeoxyglucose PET
Research · Review · PubMed · Magn Reson Imaging Clin N Am · 21 Nov 2026 - 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Clinical trial · Not yet recruiting · Phase 1/2 · Updated · ClinicalTrials.gov · 20 Nov 2026 - Studies on Tumors of the Thyroid
Clinical trial · Recruiting · Updated · ClinicalTrials.gov · 20 Nov 2026 - The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Clinical trial · Recruiting · Phase 2 · Updated · ClinicalTrials.gov · 20 Nov 2026 - Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Clinical trial · Recruiting · Phase 2 · Updated · ClinicalTrials.gov · 18 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Gallium Ga-68 dotatate privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Gallium Ga-68 dotatate in Fiala How to installMore in Cancer & imaging
- DegarelixMonthly hormone-blocking injection for advanced prostate cancer that lowers testosterone fast, without an initial flare.
- Lutetium Lu-177 dotatateTargeted radiation therapy that delivers radiation straight to neuroendocrine tumours.
- Lutetium Lu-177 vipivotide tetraxetanTargeted radiation therapy for advanced prostate cancer that carries the PSMA protein.
- MotixafortideInjection that releases stem cells from the bone marrow so they can be collected before a transplant for multiple myeloma.
- BalixafortideExperimental CXCR4 blocker studied with chemotherapy for advanced breast cancer; its Phase 3 trial failed.
- LTX-315Experimental cancer-killing peptide injected directly into tumours to trigger an immune response.